Select Equity Group, L.P. - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 459 filers reported holding REPLIGEN CORP in Q1 2021. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
Select Equity Group, L.P. ownership history of REPLIGEN CORP
ValueSharesWeighting
Q2 2022$717,000
-99.6%
4,418
-99.5%
0.00%
-99.7%
Q1 2022$176,899,000
-30.4%
940,504
-2.0%
0.57%
-17.3%
Q4 2021$254,159,000
-99.9%
959,670
-25.4%
0.69%
-44.5%
Q3 2021$371,582,186,000
+43.7%
1,285,796
-0.7%
1.25%
+41.2%
Q2 2021$258,510,495,000
+6.2%
1,295,013
+3.5%
0.88%0.0%
Q1 2021$243,324,334,000
+2.5%
1,251,604
+1.1%
0.88%
-9.3%
Q4 2020$237,330,689,000
+29.1%
1,238,484
-0.6%
0.98%
+7.9%
Q3 2020$183,828,053,000
+43.2%
1,245,954
+20.0%
0.90%
+22.7%
Q2 2020$128,336,476,000
+173.0%
1,038,237
+113.2%
0.74%
+127.5%
Q1 2020$47,016,621,000487,0170.32%
Other shareholders
REPLIGEN CORP shareholders Q1 2021
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders